These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6373386

  • 1. Studies on the effect of gonadotropin-releasing hormone and its agonist on human luteal steroidogenesis in vitro.
    Casper RF, Erickson GF, Yen SS.
    Fertil Steril; 1984 Jul; 42(1):39-43. PubMed ID: 6373386
    [Abstract] [Full Text] [Related]

  • 2. The effect of luteinizing hormone releasing hormone (LHRH) on steroidogenesis by the human luteal tissue.
    Ikoma H, Yamoto M, Nakano R.
    Acta Obstet Gynecol Scand; 1987 Jul; 66(8):695-9. PubMed ID: 3329439
    [Abstract] [Full Text] [Related]

  • 3. Modulation of cyclic AMP formation and progesterone secretion by human chorionic gonadotropin, epinephrine, buserelin and prostaglandins in normal or human chorionic gonadotropin desensitized rat immature luteal cells in monolayer culture.
    Massicotte J, Lachance R, Labrie F.
    J Steroid Biochem; 1984 Dec; 21(6):745-54. PubMed ID: 6098787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regulation of steroid hormone synthesis by human corpora lutea: failure of follicle-stimulating hormone to support steroidogenesis in vivo and in vitro.
    Devoto L, Vega M, Navarro V, Sir T, Alba F, Castro O.
    Fertil Steril; 1989 Apr; 51(4):628-33. PubMed ID: 2538370
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gonadotropin-releasing hormone-agonist inhibits synthesis of nitric oxide and steroidogenesis by luteal cells in the pregnant rat.
    Yang H, Bhat GK, Wadley R, Wright KL, Chung BM, Whittaker JA, Dharmarajan AM, Sridaran R.
    Biol Reprod; 2003 Jun; 68(6):2222-31. PubMed ID: 12606359
    [Abstract] [Full Text] [Related]

  • 14. Effects of a long-acting analogue of LH releasing hormone on human and rat corpora lutea.
    Richardson MC, Hirji MR, Thompson AD, Masson GM.
    J Endocrinol; 1984 May; 101(2):163-8. PubMed ID: 6371176
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of high-dose chorionic gonadotropin on the human and rat corpus luteum and effect of gonadotropin-releasing hormone on human luteal function.
    Caldwell BV, Rotchell YE, Pang CY, Anderson GG, Kase N, Behrman HR.
    Am J Obstet Gynecol; 1980 Feb 15; 136(4):458-64. PubMed ID: 6243862
    [Abstract] [Full Text] [Related]

  • 16. Effects of oestrogen on progesterone synthesis and arachidonic acid metabolism in human luteal cells.
    Fisch B, Rose MP, Elder MG, Winston RM, Margara RA, Hillier SG.
    Clin Endocrinol (Oxf); 1994 Jan 15; 40(1):21-32. PubMed ID: 8306476
    [Abstract] [Full Text] [Related]

  • 17. A cellular and endocrine characterization of the original and induced corpus luteum after administration of a gonadotropin-releasing hormone agonist or human chorionic gonadotropin on day five of the estrous cycle.
    Schmitt EJ, Barros CM, Fields PA, Fields MJ, Diaz T, Kluge JM, Thatcher WW.
    J Anim Sci; 1996 Aug 15; 74(8):1915-29. PubMed ID: 8856446
    [Abstract] [Full Text] [Related]

  • 18. Suppression of luteal estradiol receptors and progesterone synthesis by a gonadotropin-releasing hormone agonist (WY-40972) during midgestation.
    Sridaran R, Mahesh VB.
    Biol Reprod; 1989 Feb 15; 40(2):276-82. PubMed ID: 2655722
    [Abstract] [Full Text] [Related]

  • 19. Gonadotropin releasing hormone does not affect steroidogenesis in JEG-3 cells.
    Bauer AJ, Daniel A, Khozeimeh L, Francis GL.
    Ann Clin Lab Sci; 1998 Feb 15; 28(1):57-64. PubMed ID: 9512786
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of a gonadotropin-releasing hormone agonist on the luteal synthesis of progesterone, estradiol receptors, and prolactin surges during early pregnancy.
    Sridaran R, Ghose M, Mahesh VB.
    Endocrinology; 1988 Oct 15; 123(4):1740-6. PubMed ID: 3046924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.